Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
patatin like phospholipase domain containing 3 | 0.556 | 0.692 | 5.7E-08 |
|
phenotype | 0.100 | None | 1.000 | 4 | 4 | 2010 | 2019 | ||||||||
|
glutamic-oxaloacetic transaminase 1 | 0.601 | 0.692 | 1.2E-03 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2013 | 2019 | ||||||||
|
heparanase 2 (inactive) | 0.588 | 0.692 | 1.5E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
protein tyrosine phosphatase receptor type D | 0.584 | 0.731 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
protein phosphatase 2 regulatory subunit Balpha | 0.670 | 0.462 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
solute carrier family 35 member F2 | 0.760 | 0.231 | 2.6E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
paraoxonase 1 | 0.409 | 0.885 | 9.8E-11 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2017 | 2017 | ||||||||
|
notch receptor 4 | 0.534 | 0.731 | 2.1E-23 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
mannose receptor C-type 1 | 0.413 | 0.846 | 0.94 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | ||||||||
|
RAB, member of RAS oncogene family like 3 | 0.751 | 0.231 | 8.0E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
HECT domain E3 ubiquitin protein ligase 4 | 0.700 | 0.462 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
PDCD4 antisense RNA 1 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||||
|
glutamic-oxaloacetic transaminase 2 | 0.529 | 0.731 | 1.4E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
pumilio RNA binding family member 3 | 0.780 | 0.346 | 3.2E-26 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
complement C9 | 0.619 | 0.692 | 1.6E-24 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
CD36 molecule | 0.446 | 0.846 | 1.1E-60 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
ATP binding cassette subfamily B member 11 | 0.566 | 0.654 | 1.6E-12 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
ATP/GTP binding protein like 4 | 0.760 | 0.231 | 2.5E-06 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
chromosome 2 open reading frame 16 | 0.890 | 0.115 | 1.3E-14 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
AT-hook transcription factor | 0.805 | 0.269 | 1.3E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
SHOC2 leucine rich repeat scaffold protein | 0.593 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
Sp4 transcription factor | 0.711 | 0.423 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
potassium voltage-gated channel interacting protein 4 | 0.716 | 0.385 | 0.82 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
EF-hand domain family member D1 | 0.890 | 0.115 | 5.1E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
signal transducing adaptor molecule | 0.736 | 0.269 | 0.85 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 |